Let's break down the importance of its Amazon deal and analyze what the business is still struggling with to ... But an even ...

With transformation efforts, M&As and revenue diversification expected to boost the healthcare market, should investors ...

On that note, Terns Pharmaceuticals ( TERN -5.84%) is a biotech developing weight loss therapies that's worth investing ...

Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized ...

ATI Physical Therapy, Inc. (ATIP) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

Emily Bodnar, an analyst from H.C. Wainwright, maintained the Buy rating on IO Biotech (IOBT – Research Report). The associated price ...

Bicycle Therapeutics (BCYC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...

Sold under the brand names Mounjaro and Zepbound, tirzepatide has been an incredible growth driver for Eli Lilly. In 2022 -- the year it was first approved in the U.S. -- some analysts predicted that ...

Inogen primarily develops, manufactures and markets innovative POCs to deliver supplemental long-term oxygen therapy (LTOT) ...

Blackstone is entering an agreement with Tropical Smoothie Cafe, which started in 1997 in Destin, Florida, to purchase the food chain for nearly $2 billion. Blackstone will shell out $11 per share ...

BioMarin Pharmaceutical Inc.'s stagnant shares present a compelling investment opportunity amid uncertainty in the ...

Shares of MBX Biosciences , which is developing therapies that target endocrine and metabolic disorders, including diabetes and obesity, jumped nearly 44% in their Nasdaq debut on Friday.